Topical gel proves safe, effective treatment for patients with skin T cell lymphoma
Results of a phase one trial show that an investigational topical drug, resiquimod gel, causes regression of both treated and untreated tumor lesions and may completely remove cancerous cells from both sites in patients with ...
Aug 6, 2015
0
5